These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31051945)

  • 21. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer.
    Alexiou E; Georgoulias P; Valotassiou V; Georgiou E; Fezoulidis I; Vlychou M
    Hell J Nucl Med; 2015; 18(1):77-8. PubMed ID: 25679079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
    Peller PJ; Ho VB; Kransdorf MJ
    Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Liu S; Xie J; Yu F; Cai H; Wu F; Zheng H; Ma C; Lv Z; Wang H
    Cancer Manag Res; 2020; 12():2449-2457. PubMed ID: 32308481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental Tc-99m MDP Uptake in Cortical-subcortical Parietotemporal Cerebral Area in a Patient with a History of Recent Ischemic Cerebrovascular Event who Underwent Whole-body Bone Scan.
    Nak D; Göksel S
    Mol Imaging Radionucl Ther; 2023 Feb; 32(1):65-67. PubMed ID: 36820007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
    Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
    Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidental Hydroxyapatite Ocular Implant Uptake on Bone Scan Done for Prostate Cancer Staging: Case Report and Brief Review.
    Chaussé G; Laufer J; Abikhzer G; Probst S
    Mol Imaging Radionucl Ther; 2019 Jun; 28(2):86-88. PubMed ID: 31237141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma.
    Sood A; Seam RK; Sethi S; Gupta M
    Indian J Nucl Med; 2010 Apr; 25(2):70-2. PubMed ID: 21188069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
    MacDonald J
    J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dural metastasis demonstrated on Tc-99m MDP bone scintigraphy in staging workup for a patient with breast cancer.
    Truong MX; Ting AC; Rossleigh MA; Carroll SL
    Clin Nucl Med; 2006 Apr; 31(4):223-4. PubMed ID: 16550022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extraosseous accumulation of bone scan tracer (99m)Tc-methylene diphosphonate in a phlebolith.
    Kulkarni M; Agrawal A; Zade A; Purandare N; Shah S; Rangarajan V
    Indian J Nucl Med; 2012 Jan; 27(1):42-4. PubMed ID: 23599599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
    Kim SJ; Choi JY; Lee JH; Hyun SH; Cho YS; Moon SH; Choe YS; Lee KH; Kim BT
    Nuklearmedizin; 2016 Aug; 55(4):166-71. PubMed ID: 26632485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
    Amin A; El-Kareem MA; Yahia AB
    Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of
    Parghane RV; Singh B; Sharma A; Singh H; Singh P; Bhattacharya A
    J Nucl Med Technol; 2017 Dec; 45(4):280-284. PubMed ID: 28798229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of
    Zhang L; He Q; Li W; Zhang R
    BMC Med Imaging; 2017 Jul; 17(1):46. PubMed ID: 28738834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.